Document:

Exhibit 10.107

 

 

 

November 23, 2016

 

 

 

 

Kathleen Valiasek

 

 

 

 

Dear Kathy:

 

On behalf of Amyris, Inc. (“Amyris” or the “Company”),
I am delighted to offer to you employment with Amyris. If you accept this offer and satisfy the conditions of acceptance set forth
herein, your employment with Amyris will commence on January 4, 2017, or on a different date mutually agreed to by both parties,
under the following terms:

 

Position

You will be employed full-time by Amyris as Chief Financial Officer (CFO) reporting to
John Melo, CEO.

 

Salary

Your base salary will be $350,000 per year ($29,167 per month) payable in accordance
with Amyris’ regular payroll schedule which is currently semi-monthly. Your salary will be subject to adjustment from time
to time pursuant to the Company’s employee compensation policies then in effect.

 

Bonus

You will be eligible for a discretionary performance-based bonus, with your initial aggregate
annual bonus target being $115,500.00. Such bonus shall be earned and paid out in accordance with the applicable executive bonus
plan adopted by the Company for each year.

 

Benefits

You will be eligible to participate in the employee benefits and benefit plans that are
available to full-time employees of Amyris. Currently, these include (i) 12 paid holidays, (ii) three weeks of paid vacation (pro-rated
by hiring date), (iii) up to six days of paid sick leave per year (pro-rated by hiring date), (iv) medical insurance, (v) dental
insurance, (vi) vision insurance, (vii) supplemental health and flexible spending accounts, (viii) group term life insurance, (ix)
accidental death & disability insurance, (x) long-term disability insurance, and (xi) 401K plan. You will also be eligible
to receive paid access to adjacent gym facilities. The terms of your benefits will be governed by the applicable plan documents
and Amyris’ company policies. Enclosed is an Employee Benefits Overview.

 

    	1

     

    

Equity

Amyris will recommend to its Board of Directors or the relevant committee of the Board
of Directors that you be granted (i) an option to purchase 250,000 shares of common stock of Amyris; and (ii) an award of 167,000
restricted stock units (“RSUs”). The option would have an exercise price per share equal to the fair
market value of a share of Amyris common stock on the date of grant (generally the closing price of Amyris common stock on NASDAQ
as of the date of grant) and vest as follows: (i) 50,000 shares will vest upon completion of six months of employment, and (ii)
25% of the remaining shares subject to the option upon completion of your twelfth month of employment, and (iii) the balance of
the shares subject to the option in a series of 36 equal monthly instalments upon completion of each additional month of employment
with Amyris thereafter. The 167,000 share RSU awards would vest in equal annual instalments over three years from the vesting commencement
date. Any option(s) or RSU award(s) granted to you will be granted as of a date set in accordance with Amyris’ standard equity
award granting policy and subject to the then-current terms and conditions of the relevant Amyris equity plan and agreements.

 

Amyris’ Company Policies

As an employee of Amyris, you will be subject to, and expected to comply with its policies
and procedures, personnel and otherwise, as such policies are developed and communicated to you.

 

“At-Will” Employment

Employment with Amyris is “at-will”. This means that it is not for any specified
period of time and can be terminated by you or by Amyris at any time, with or without advance notice, and for any or no particular
reason or cause. It also means that your job duties, title and responsibility and reporting level, compensation and benefits, as
well as Amyris’ personnel policies and procedures, may be changed at any time in the sole discretion of Amyris. However,
the “at-will” nature of your employment shall remain unchanged during your tenure as an employee of Amyris and may
not be changed, except in an express writing signed by you and by an authorized Amyris executive officer signing on behalf of Amyris.

 

Termination and Change in Control Benefits

As an executive of Amyris, you will be eligible to participate in the Company’s
Executive Severance Plan (the “Severance Plan”), a copy of which is attached hereto as Exhibit
A. In order to participate in the Severance Plan, you will be required to execute the “Participation Agreement”
in the form attached to the Severance Plan and to comply with the other terms of the Severance Plan.

 

Full-Time Service to Amyris

Amyris requires that, as a full-time employee, you devote your full business time, attention,
skills and efforts to the tasks and duties of your position as assigned by Amyris. If you wish to request consent to provide services
(for any or no form of compensation) to any other person or business entity while employed by Amyris, you must first receive permission
from an officer of Amyris.

 

Conditions of Offer

In order to accept this offer, and for your acceptance to be effective, you must satisfy
the following conditions:

 

		1.	You must provide satisfactory documentary proof of your identity and right to work in the United States of America on your
first day of employment.

 

    	2

     

    

 

	2.	You must agree in writing to the terms of the enclosed Proprietary Information and Inventions Agreement (“PIIA”)
without modification.
	 	 

	3.	You must consent to, and Amyris must obtain satisfactory results from, reference and background checks. Until you have been
informed in writing by Amyris that such checks have been completed and the results satisfactory, you may wish to defer reliance
on this offer.
	 	 

		4.	You must agree in writing to the terms of the enclosed Mutual Agreement to Binding Arbitration (“Arbitration Agreement”)
without modification.

 

By signing and accepting this offer, you represent and warrant that: (i) you are not
subject to any pre-existing contractual or other legal obligation with any person, company or business enterprise which may be
an impediment to your employment with, or your providing services to, Amyris as its employee; and (ii) you have not and shall not
bring onto Amyris’ premises, or use in the course of your employment with Amyris, any confidential or proprietary information
of another person, company or business enterprise to whom you previously provided services.

 

Entire Agreement

Provided that the conditions of this offer and your acceptance are satisfied, this letter
together with the enclosed PIIA and Arbitration Agreement (collectively, the “Offer Documents”) shall constitute the
full and complete agreement between you and Amyris regarding the terms and conditions of your employment. The Offer Documents cancel,
supersede and replace any and all prior negotiations, representations or agreements, written and oral, between you and Amyris or
any representative or agent of Amyris regarding any aspect of your employment. Any change to the terms of your employment with
Amyris, as set forth in this letter, must be in an individualized writing to you, signed by Amyris to be effective.

 

Please confirm your acceptance of this offer, by signing and returning the enclosed copy
of this letter as well as the PIIA and Arbitration Agreement to Christine Ofori, CHRO by November 28, 2016. If not accepted by
you as of that date, this offer will expire. We look forward to having you join Amyris. If you have any questions, please do not
hesitate to contact me at 

 

Sincerely,

 

/s/ Christine Ofori

 

Christine Ofori

Chief Human Resources Officer

 

 

 

 

    	3

     

    

I HAVE READ AND ACCEPT THIS EMPLOYMENT OFFER:

 

 

	/s/ Kathleen Valiasek	 	11/28                , 2016
	Kathleen Valiasek	 	Date
	 	 	 

 

Enclosures:

Proprietary Information and Inventions Agreement

Mutual Agreement to Arbitrate

Employee Benefits Overview

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4Exhibit 10.119

 

Description of Non-Employee Director Compensation Arrangements

 

In December 2010, the Board of Directors (the
“Board”) of Amyris, Inc. (the “Company”)
adopted a non-employee director compensation program (the “Program”)
that took effect on January 1, 2011. In February 2012, October 2013, November 2013 and November 2014, the Leadership Development
and Compensation Committee of the Board (the “LDCC”) determined that
it would not recommend to the Board any changes to the Program for 2012, 2013, 2014 or 2015, respectively. In February 2015, due
to the commitment required for the role and consistent with similarly situated companies, the Board approved an increase to the
annual cash retainer payable to the chair of the Audit Committee of the Board (the “Audit
Committee”) from $15,000 to $30,000, effective January 1, 2015. In November 2015, the LDCC recommended to
the Board that it increase the equity component of the Program to provide for awards at approximately the 50th market
percentile. In December 2015, the Board approved an increase to the equity component of the Program, which had previously consisted
of an initial award upon joining the Board of an option to purchase 20,000 shares of the Company’s common stock (“Common
Stock”) and an annual award consisting of an option to purchase 6,000 shares of Common Stock and 3,000 restricted
stock units. In October 2016, the LDCC further recommended to the Board that it add an annual retainer for the position of non-executive
Board chair in the form of an award of 35,000 restricted stock units to the Program, which the Board approved in November 2016.
Under the amended Program, in each case subject to final approval by the Board with respect to equity awards:

 

		·	Each non-employee director receives an annual cash retainer of $40,000, an initial award upon joining
the Board consisting of an option to purchase 45,000 shares of Common Stock and 30,000 restricted stock units, and an annual award
consisting of an option to purchase 26,000 shares of Common Stock and 17,000 restricted stock units. The initial option award vests
in equal quarterly installments over three years, the initial restricted stock unit award vests in equal annual installments over
three years, and the annual option and restricted stock unit awards become fully vested after one year (in each case subject to
continued service through the applicable vesting date).

 

		·	The non-executive Board chair receives an additional annual award of 35,000 restricted stock units.
The award becomes fully vested after one year (subject to continued service through the vesting date).

 

		·	The chair of the Audit Committee receives an additional annual cash retainer of $30,000.

 

		·	The chair of the LDCC receives an additional annual cash retainer of $10,000.

 

		·	The chair of the Nominating and Governance Committee of the Board (the “NGC”)
receives an additional annual cash retainer of $9,000.

 

		·	Audit Committee, LDCC and NGC members other than the chair receive an additional annual cash retainer
of $7,500, $5,000 and $4,500, respectively.

 

In general, all of the retainers
described above are paid quarterly in arrears. In cases where a non-employee director serves for part of the year in a capacity
entitling him or her to a retainer payment, the retainer is prorated to reflect his or her period of service in that capacity.
Non-employee directors are also eligible for reimbursement of their expenses incurred in attending Board and committee meetings.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]